(Q35796302)

10 August 2017

0 references

Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis (English)

1 reference

10 August 2017

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Stefano Cascinu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1

Roberto Iacovelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Franco Nolè

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Elena Verri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Giuseppe Renne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Chiara Paglino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Maria Cossu Rocca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Palma Giglione

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Gaetano Aurilio

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Daniela Cullurà

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Camillo Porta

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

2 October 2015

1 reference

10 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

143-148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26429561%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11523-015-0392-7

4 June 2020

exact match

0 references

cites work

Nivolumab plus ipilimumab in advanced melanoma

1 reference

12 December 2020

Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

1 reference

12 December 2020

PD-L1 expression in nonclear-cell renal cell carcinoma

1 reference

12 December 2020

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

1 reference

12 December 2020

Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma.

1 reference

12 December 2020

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

1 reference

12 December 2020

Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial

1 reference

12 December 2020

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

1 reference

12 December 2020

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

1 reference

12 December 2020

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

12 December 2020

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

12 December 2020

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

1 reference

12 December 2020

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

1 reference

12 December 2020

Nivolumab in previously untreated melanoma without BRAF mutation

1 reference

12 December 2020

The prognostic value of PD-L1 expression for non-small cell lung cancer patients: a meta-analysis.

1 reference

12 December 2020

PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

1 reference

12 December 2020

Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer.

1 reference

12 December 2020

Global estimates of cancer prevalence for 27 sites in the adult population in 2008.

1 reference

12 December 2020

Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma

1 reference

12 December 2020

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

12 December 2020

PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases

1 reference

12 December 2020